Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

119 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Real World Data from an Italian Outpatient Clinical Setting and from Home Care Assistance of Treatment-Experienced PWH Switching to CAB + RPV Regimen: A Prospective Observational Study.
Iannone V, Lombardi F, Ciccullo A, Lamanna F, Salvo PF, Sanfilippo A, Baldin G, Borghetti A, Torti C, Di Giambenedetto S. Iannone V, et al. Among authors: ciccullo a. AIDS Behav. 2025 Jan 9. doi: 10.1007/s10461-024-04597-4. Online ahead of print. AIDS Behav. 2025. PMID: 39779624
Effectiveness of bictegravir/emtricitabine/tenofovir alafenamide (BIC/FTC/TAF) as switch strategy in virologically-suppressed patients: real world data from a monocentric cohort.
Passerotto RA, Lamanna F, Salvo PF, Iannone V, Steiner RJ, Carbone A, Farinacci D, D'Angelillo A, Baldin G, Ciccullo A, Di Giambenedetto S, Torti C, Borghetti A. Passerotto RA, et al. Among authors: ciccullo a. Antivir Ther. 2024 Dec;29(6):13596535241306467. doi: 10.1177/13596535241306467. Antivir Ther. 2024. PMID: 39698926 Free article.
Comparing the long-term effectiveness and safety of dolutegravir/lamivudine versus bictegravir/emtricitabine/tenofovir alafenamide fumarate as first-line regimens: a real life multicentre cohort.
Ciccullo A, Baldin G, Cervo A, Moschese D, Lagi F, Cossu MV, Grimaldi A, Giacomelli A, Rusconi S, Sterrantino G, Borghetti A, Antinori S, Mussini C, Di Giambenedetto S. Ciccullo A, et al. J Antimicrob Chemother. 2025 Jan 3;80(1):175-177. doi: 10.1093/jac/dkae392. J Antimicrob Chemother. 2025. PMID: 39478330
Investigating seroprevalence of IgG antibodies against Monkeypox Virus (MPXV) in a cohort of people living with HIV (PLWH) in Rome, during the 2022 outbreak: Moving beyond traditional at-risk populations.
Salvo PF, Sanfilippo A, Baldin G, Iannone V, Ciccullo A, Farinacci D, Benvenuto D, Borghetti A, Di Giambenedetto S, Lombardi F. Salvo PF, et al. Among authors: ciccullo a. Travel Med Infect Dis. 2024 Nov-Dec;62:102757. doi: 10.1016/j.tmaid.2024.102757. Epub 2024 Sep 4. Travel Med Infect Dis. 2024. PMID: 39241937 Free article.
Autochthonous dengue outbreak in Rome, Italy, in 2023.
Salvo PF, Baldin G, Raffaelli F, Ciccullo A, Borghetti A, Tamburrini E, Ricci R, Di Donato M, Di Giambenedetto S, Torti C. Salvo PF, et al. Among authors: ciccullo a. J Travel Med. 2024 Oct 19;31(7):taae111. doi: 10.1093/jtm/taae111. J Travel Med. 2024. PMID: 39180338 No abstract available.
HIV and vicarious stigma in a cohort of people living with HIV in Italy: What happens when the stigma is fueled by healthcare providers?
Massaroni V, Iannone V, Donne VD, D'Angelillo A, Baldin G, Passerotto R, Sangiorgi F, Steiner RJ, Ciccullo A, Borghetti A, Visconti E, Giambenedetto SD. Massaroni V, et al. Among authors: ciccullo a. AIDS Care. 2024 Oct;36(10):1441-1451. doi: 10.1080/09540121.2024.2361820. Epub 2024 Jun 4. AIDS Care. 2024. PMID: 38833545
Treatment Experienced People Living With HIV switching to DOR/3TC/TDF in Outpatient Setting: Real-World Data on Tolerability and Cost Savings From an Italian Multicenter Cohort.
Iannone V, Ciccullo A, Moschese D, Giacomelli A, Fabbiani M, Lagi F, Papalini C, De Vito A, Cossu MV, Di Giambenedetto S, Borghetti A. Iannone V, et al. Among authors: ciccullo a. J Acquir Immune Defic Syndr. 2024 Jun 1;96(2):e10-e11. doi: 10.1097/QAI.0000000000003427. J Acquir Immune Defic Syndr. 2024. PMID: 38771757 No abstract available.
Efficacy of Lamivudine Plus Dolutegravir vs Dolutegravir-Based 3-Drug Regimens in People With HIV Who Are Virologically Suppressed.
Borghetti A, Ciccullo A, Lombardi F, Giannarelli D, Passerotto RA, Lamanna F, Carcagnì A, Farinacci D, Dusina A, Baldin G, Zazzi M, Di Giambenedetto S. Borghetti A, et al. Among authors: ciccullo a. Open Forum Infect Dis. 2024 Apr 10;11(5):ofae198. doi: 10.1093/ofid/ofae198. eCollection 2024 May. Open Forum Infect Dis. 2024. PMID: 38680613 Free PMC article.
119 results